SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 30.02+0.7%11:03 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (16036)9/5/2002 9:15:40 AM
From: Robert K.  Read Replies (1) of 17367
 
And I quote>>> "DR. BRETT GIROIR: Right now the study is over and BPI is not yet approved. So if one of
my children came into the hospital today with meningococcal sepsis, they couldn't get
BPI, even though I know it works. There's no way to supply it."

My comment>shame on the fda for not approving a supposedly safe drug for children. Shame, shame. I am glad I dont have that decision on my conscience. I am GLAD DR Girior is STILL in there fighting for those kids. I am sure it is especially hard for him to experience those cases with the
belief he has that a treatment COULD be made available.
That must be heartwrenching. Dr Girior is on the advisory board of cepheid so I think maybe he has another angle to play. GO get-em DR G. Standard K disclaimers always all IMO no facts. ALSO>while xoma/baxter does NOT fall into the same category of the FDA>the lack of speed/effort on their part does not sit well with me at all.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext